$11.930
+0.122 (+1.02%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MLTX Prediction & Forecast by Similar Chart Analysis
Alphio's MLTX stock price prediction model matches the current MoonLake Immunotherapeutics tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.89 (-0.31%). The 1-week path is $11.85 (-0.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy MoonLake Immunotherapeutics Stock?
MoonLake Immunotherapeutics is a good buy right now due to its current price of $11.85, which is significantly lower than the analyst price targets of $50 and $70, indicating a potential upside of over 320%. Additionally, the stock has shown a recent 5-day change of +24.08%, reflecting positive momentum. However, investors should be cautious of the company's ongoing losses, with an EPS of -0.84 reported in the last quarter, indicating the main risk associated with the investment.
MLTX stock price ended at $11.93 on Tuesday, after rising +1.02%
MoonLake Immunotherapeutics (MLTX) last closed at $11.9300003, gaining +1.02%. These facts feed the 1-day and 1-week MLTX price prediction above.
Forecast Drivers
MoonLake Immunotherapeutics (MLTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MLTX, ranked by similarity.
Seasonality analysis for MLTX
Historically the probability of a positive October return for MLTX is 1.54%. August offers the highest probability of a positive month at 53.12%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MLTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $43.26 | $52.83 | $62.28 | +342.80% |
| Nov 2026 | $55.25 | $64.11 | $67.12 | +437.35% |
| Dec 2026 | $46.62 | $47.38 | $48.66 | +297.17% |
In 2026, MoonLake Immunotherapeutics (MLTX) is projected to range from $43.26 to $67.12.
MoonLake Immunotherapeutics 2026 monthly forecast
In Oct 2026, MoonLake Immunotherapeutics is projected to average $52.83, with a low of $43.26 and high of $62.28.
In Nov 2026, MoonLake Immunotherapeutics is projected to average $64.11, with a low of $55.25 and high of $67.12.
In Dec 2026, MoonLake Immunotherapeutics is projected to average $47.38, with a low of $46.62 and high of $48.66.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.